4.41
price up icon2.32%   0.10
after-market Dopo l'orario di chiusura: 4.39 -0.02 -0.45%
loading
Precedente Chiudi:
$4.31
Aprire:
$4.35
Volume 24 ore:
4.12M
Relative Volume:
1.42
Capitalizzazione di mercato:
$628.67M
Reddito:
$181.41M
Utile/perdita netta:
$-59.56M
Rapporto P/E:
-10.50
EPS:
-0.42
Flusso di cassa netto:
$-38.83M
1 W Prestazione:
+9.70%
1M Prestazione:
-20.97%
6M Prestazione:
+36.53%
1 anno Prestazione:
+152.00%
Intervallo 1D:
Value
$4.30
$4.5401
Intervallo di 1 settimana:
Value
$4.00
$4.5401
Portata 52W:
Value
$1.71
$6.07

Xeris Biopharma Holdings Inc Stock (XERS) Company Profile

Name
Nome
Xeris Biopharma Holdings Inc
Name
Telefono
844-445-5704
Name
Indirizzo
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Name
Dipendente
394
Name
Cinguettio
@XerisPharma
Name
Prossima data di guadagno
2024-12-08
Name
Ultimi documenti SEC
Name
XERS's Discussions on Twitter

Confronta XERS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XERS
Xeris Biopharma Holdings Inc
4.41 628.67M 181.41M -59.56M -38.83M -0.42
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-11 Downgrade Piper Sandler Overweight → Neutral
2024-03-28 Iniziato Oppenheimer Outperform
2023-08-28 Iniziato Craig Hallum Buy
2022-10-21 Iniziato Jefferies Buy
2022-04-28 Iniziato Craig Hallum Buy
2021-11-17 Iniziato SVB Leerink Outperform
2021-10-29 Iniziato H.C. Wainwright Buy
2021-04-07 Ripresa RBC Capital Mkts Outperform
2020-02-18 Iniziato Piper Sandler Overweight
2018-07-16 Iniziato Jefferies Buy
2018-07-16 Iniziato Leerink Partners Outperform
2018-07-16 Iniziato RBC Capital Mkts Outperform
Mostra tutto

Xeris Biopharma Holdings Inc Borsa (XERS) Ultime notizie

pulisher
08:23 AM

Recent Insider Activity Suggests Potential Gains for Xeris Biopharma Holdings Inc (XERS) - knoxdaily.com

08:23 AM
pulisher
Apr 27, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Bought by Russell Investments Group Ltd. - Defense World

Apr 27, 2025
pulisher
Apr 26, 2025

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit - Yahoo

Apr 26, 2025
pulisher
Apr 25, 2025

Xeris Biopharma Holdings Inc’s Banking’s 100-Day Moving Average at 3.96: Will the Stock Break Through? - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Xeris Biopharma Holdings Inc (XERS) Performance and Fundamentals Dashboard tells a completely different story - Sete News

Apr 25, 2025
pulisher
Apr 23, 2025

Understanding the Risks of Investing in Xeris Biopharma Holdings Inc (XERS) - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 23, 2025
pulisher
Apr 22, 2025

Is Xeris Biopharma Holdings Inc. (XERS) the Best Multibagger Penny Stock to Buy According to Billionaires? - Insider Monkey

Apr 22, 2025
pulisher
Apr 22, 2025

10 Best Multibagger Penny Stocks to Buy According to Billionaires - Insider Monkey

Apr 22, 2025
pulisher
Apr 22, 2025

Are Xeris Biopharma Holdings Inc (XERS) shares a good deal now? - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Market Watch: Xeris Biopharma Holdings Inc (XERS)’s Noteworthy Drop, Closing at 4.02 - DWinneX

Apr 22, 2025
pulisher
Apr 21, 2025

JPMorgan Chase & Co. Has $3.54 Million Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Apr 21, 2025
pulisher
Apr 21, 2025

Alliancebernstein L.P. Reduces Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Apr 21, 2025
pulisher
Apr 17, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Sees Large Growth in Short Interest - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Acquired by Vanguard Group Inc. - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Raymond James Financial Inc. Makes New Investment in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Wellington Management Group LLP Sells 6,532 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Purchased by Prudential Financial Inc. - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Holdings Lowered by Corebridge Financial Inc. - Defense World

Apr 12, 2025
pulisher
Apr 02, 2025

Xeris Biopharma Holdings Inc [XERS] stock was sold by Hecht Beth at the price of US$0.22 million - knoxdaily.com

Apr 02, 2025
pulisher
Mar 31, 2025

AIGH Capital Management LLC Purchases 389,192 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

Auto-Injectors Market Growth in Future Scope 2025-2032 | Sanofi - openPR

Mar 31, 2025
pulisher
Mar 28, 2025

Xeris Pharmaceuticals Announces Board Changes with New Appointment - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Xeris Biopharma reshuffles board, appoints new director By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Xeris Announces Changes To Its Board Of Directors - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Xeris Biopharma reshuffles board, appoints new director - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Xeris Announces Changes to Its Board of Directors - Business Wire

Mar 28, 2025
pulisher
Mar 27, 2025

Is Xeris Biopharma Holdings (XERS) The Hot Biotech Stock Under $5? - Insider Monkey

Mar 27, 2025
pulisher
Mar 25, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Sold by Bank of New York Mellon Corp - Defense World

Mar 25, 2025
pulisher
Mar 23, 2025

Don't Ignore The Insider Selling In Xeris Biopharma Holdings - simplywall.st

Mar 23, 2025
pulisher
Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Has $581,000 Stock Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Mar 23, 2025
pulisher
Mar 23, 2025

Xeris Biopharma (NASDAQ:XERS) Stock Price Up 4.9% – Here’s Why - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Xeris Biopharma chief legal officer Beth Hecht sells $217,244 in stock - Investing.com India

Mar 22, 2025
pulisher
Mar 21, 2025

Xeris Biopharma chief legal officer Beth Hecht sells $217,244 in stock By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

Xeris Pharmaceuticals stock hits 52-week high at $5.54 - Investing.com

Mar 21, 2025
pulisher
Mar 21, 2025

Xeris Pharmaceuticals stock hits 52-week high at $5.54 By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 20, 2025

Strength Seen in Xeris Biopharma (XERS): Can Its 5.6% Jump Turn into More Strength? - Yahoo Finance

Mar 20, 2025
pulisher
Mar 20, 2025

Xeris Biopharma (NASDAQ:XERS) Reaches New 52-Week High – Time to Buy? - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Xeris Biopharma Holdings (XERS): Among the Best Stocks to Invest in for a Stock Market Game - Insider Monkey

Mar 19, 2025
pulisher
Mar 19, 2025

Xeris enters a whole new market for one of its main pharma offerings - Crain's Chicago Business

Mar 19, 2025
pulisher
Mar 19, 2025

Is XERS Stock a Good Buy in 2025? Key Insights for Investors - Stocks Telegraph

Mar 19, 2025
pulisher
Mar 18, 2025

12 Best Stocks to Invest in for a Stock Market Game - Insider Monkey

Mar 18, 2025
pulisher
Mar 18, 2025

Xeris Biopharma gets FDA nod for Gvoke VialDx, teams with American Regent - Investing.com Australia

Mar 18, 2025
pulisher
Mar 17, 2025

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid - BioSpace

Mar 17, 2025
pulisher
Mar 17, 2025

Xeris Biopharma Says US FDA Approves Gvoke VialDx for Diagnostic Use -March 17, 2025 at 08:33 am EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Xeris Biopharma gets FDA nod for Gvoke VialDx, teams with American Regent By Investing.com - Investing.com South Africa

Mar 17, 2025

Xeris Biopharma Holdings Inc Azioni (XERS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
Capitalizzazione:     |  Volume (24 ore):